Boardroom Alpha
Boardroom Alpha
GCO · Additional Proxy Materials (DEFA14A) · Filed July 8, 2026

Genesco Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
July 8, 2026
Ticker
GCO
Accession
0001193125-26-298733
Boardroom Alpha · Filing insights

Genesco reports ISS backs its nine-director slate and urges voting FOR Genesco on the WHITE card.

Proxy advisor rec.
About Genesco Inc
Market cap
$380M
1Y TSR
+6.1%
3Y TSR
+4.3%
Board grade
C+
Sector
Consumer Cyclical
CEO
Mimi E Vaughn
Last annual meeting: Jun 26, 2025 · View full Genesco Inc profile →
DEFA14A
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. ____)

 

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐  Preliminary Proxy Statement

☐  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐  Definitive Proxy Statement

☒  Definitive Additional Materials

☐  Soliciting Material under §240.14a-12

Genesco Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒  No fee required.

☐  Fee paid previously with preliminary materials.

☐  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 
 


 

The Company sent the following communication to its employees.

 

 


I want to share an important update as we approach our Annual Meeting on July 21.

As you likely know, one of our shareholders, Bradley Radoff, has nominated two candidates to stand for election to our Board in opposition to Genesco’s nine director nominees.

Earlier this week, Institutional Shareholder Services (ISS), the leading independent proxy advisory firm, recommended that Genesco shareholders vote FOR all nine of Genesco’s director nominees. ISS concluded that there was no compelling case made for change and that our company has good momentum and the right board. We are pleased that their report recognizes the Company’s strategic progress, operational improvements and performance, underscoring the progress we’ve made together.

In terms of what this means to you, it’s business as usual. A small team is managing the proxy process so the rest of the organization can stay focused on serving our customers, delivering our Plan and building on our momentum. Your hard work and dedication demonstrated every day is what drives our success and that remains our priority.

As a reminder, if you are a Genesco shareholder, your vote is important. Our Board unanimously recommends that shareholders vote FOR ONLY Genesco’s nine director nominees on the WHITE proxy card and discard any gold proxy card you may receive. If you need assistance voting your shares, please contact our proxy solicitor, Innisfree M&A, at (877) 750-2689 (U.S. and Canada) or +1 (412) 232-3651 (international). For resources on the proxy vote, please visit www.VoteGenesco.com.

Thank you for your ongoing commitment and for all you do for Genesco.

Mimi E. Vaughn

Board Chair, President and Chief Executive Officer

Genesco Inc.

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Genesco Inc (GCO)

Reference

Frequently asked questions

When did Genesco Inc file this DEFA14A?
Genesco Inc (GCO) filed this Additional Proxy Materials (DEFA14A) with the SEC on July 8, 2026. The accession number assigned by EDGAR is 0001193125-26-298733.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Genesco reports ISS backs its nine-director slate and urges voting FOR Genesco on the WHITE card. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Proxy advisor rec.". It appears above the filing body as a labeled pill.
Where can I find Genesco Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Genesco Inc has filed under CIK 18498, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer